{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T18:11:26Z","timestamp":1774548686331,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,9]],"date-time":"2016-05-09T00:00:00Z","timestamp":1462752000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Dutch Kidney Foundation consortium","award":["CP09.04"],"award-info":[{"award-number":["CP09.04"]}]},{"name":"Alexander von Humboldt (AvH) foundation"},{"name":"AvH and TTS fellowships"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.trim.2016.04.008","type":"journal-article","created":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T13:06:11Z","timestamp":1462107971000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Added effects of dexamethasone and mesenchymal stem cells on early Natural Killer cell activation"],"prefix":"10.1016","volume":"37","author":[{"given":"Clive M.","family":"Michelo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Fasse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bram","family":"van Cranenbroek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Linda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnold","family":"van der Meer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heba","family":"Abdelrazik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irma","family":"Joosten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2016.04.008_bb0005","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1182\/blood.V98.13.3595","article-title":"Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality","volume":"98","author":"Khouri","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.trim.2016.04.008_bb0010","doi-asserted-by":"crossref","DOI":"10.1136\/archdischild-2013-304832","article-title":"Recent advances in the management of graft-versus-host disease","author":"Dhir","year":"2014","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.trim.2016.04.008_bb0015","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/imr.12154","article-title":"Transplantation tolerance: from theory to clinic","volume":"258","author":"Fuchs","year":"2014","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.trim.2016.04.008_bb0020","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/cmi.2013.56","article-title":"Selective expansion of human natural killer cells leads to enhanced alloreactivity","volume":"11","author":"Eissens","year":"2014","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.trim.2016.04.008_bb0025","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1111\/j.1600-6143.2011.03621.x","article-title":"KIR-ligand mismatches are associated with reduced long-term graft survival in HLA-compatible kidney transplantation","volume":"11","author":"van Bergen","year":"2011","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2016.04.008_bb0030","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/MOH.0b013e3283590395","article-title":"Natural killer cell alloreactivity 10 years later","volume":"19","author":"Velardi","year":"2012","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.trim.2016.04.008_bb0035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fimmu.2014.00087","article-title":"Human NK Cells: From Surface Receptors to the Therapy of Leukemias and Solid Tumors","volume":"5","author":"Moretta","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2016.04.008_bb0040","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1681\/ASN.V1061366","article-title":"Newer immunosuppressive drugs: a review","volume":"10","author":"Gummert","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2016.04.008_bb0045","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.4049\/jimmunol.136.4.1315","article-title":"Immunosuppressive effects of cyclosporin A on cloned T cells","volume":"136","author":"Herold","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.trim.2016.04.008_bb0050","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF02171743","article-title":"Mycophenolate mofetil: Molecular mechanisms of action","volume":"2","author":"Wu","year":"1994","journal-title":"Perspect. Drug Discovery Des."},{"key":"10.1016\/j.trim.2016.04.008_bb0055","doi-asserted-by":"crossref","first-page":"9573","DOI":"10.1073\/pnas.160099797","article-title":"Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids","volume":"97","author":"Bianchi","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trim.2016.04.008_bb0060","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/bies.950180507","article-title":"Molecular mechanisms of anti-inflammatory action of glucocorticoids","volume":"18","author":"Cato","year":"1996","journal-title":"BioEssays"},{"key":"10.1016\/j.trim.2016.04.008_bb0065","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1002\/eji.200425418","article-title":"The corticosteroid-induced inhibitory effect on NK cell function reflects down-regulation and\/or dysfunction of triggering receptors involved in natural cytotoxicity","volume":"34","author":"Vitale","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.trim.2016.04.008_bb0070","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1182\/blood-2006-07-037846","article-title":"Molecular analysis of the methylprednisolone-mediated inhibition of NK-cell function: evidence for different susceptibility of IL-2- versus IL-15-activated NK cells","volume":"109","author":"Chiossone","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.trim.2016.04.008_bb0075","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1002\/stem.1494","article-title":"Concise review: combining human leukocyte antigen G and mesenchymal stem cells for immunosuppressant biotherapy","volume":"31","author":"Naji","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.trim.2016.04.008_bb0080","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MOT.0000000000000035","article-title":"Mesenchymal stromal cells to promote kidney transplantation tolerance","volume":"19","author":"Casiraghi","year":"2014","journal-title":"Curr. Opin. Organ Transplant."},{"key":"10.1016\/j.trim.2016.04.008_bb0085","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2215\/CJN.04950610","article-title":"Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility","volume":"6","author":"Perico","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2016.04.008_bb0090","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.4049\/jimmunol.181.6.3933","article-title":"Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells","volume":"181","author":"Casiraghi","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.trim.2016.04.008_bb0095","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.trim.2016.04.008_bb0100","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1111\/j.1600-6143.2010.03242.x","article-title":"Rapamycin and MPA, but not CsA, impair human NK cell cytotoxicity due to differential effects on NK cell phenotype","volume":"10","author":"Eissens","year":"2010","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2016.04.008_bb0105","doi-asserted-by":"crossref","first-page":"e60144","DOI":"10.1371\/journal.pone.0060144","article-title":"Impact of commonly used transplant immunosuppressive drugs on human NK cell function is dependent upon stimulation condition","volume":"8","author":"Meehan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.trim.2016.04.008_bb0110","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1182\/blood-2007-02-074997","article-title":"Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2.3-dioxygenase and prostaglandin E2","volume":"111","author":"Spaggiari","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.trim.2016.04.008_bb0115","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/biof.107","article-title":"Cytokine regulation of natural killer cell effector functions","volume":"36","author":"Zwirner","year":"2010","journal-title":"Biofactors"},{"key":"10.1016\/j.trim.2016.04.008_bb0120","doi-asserted-by":"crossref","first-page":"7307","DOI":"10.1073\/pnas.92.16.7307","article-title":"Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes","volume":"92","author":"Bacon","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trim.2016.04.008_bb0125","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.4049\/jimmunol.164.12.6244","article-title":"IL-2 activation of NK cells: involvement of MKK1\/2\/ERK but not p38 kinase pathway","volume":"164","author":"Yu","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.trim.2016.04.008_bb0130","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1089\/hum.2011.039","article-title":"Immunological aspects of allogeneic and autologous mesenchymal stem cell therapies","volume":"22","author":"Hoogduijn","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.trim.2016.04.008_bb0135","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1078\/0171-2985-00219","article-title":"Functional significance of the activation-associated receptors CD25 and CD69 on human NK-cells and NK-like T-cells","volume":"207","author":"Clausen","year":"2003","journal-title":"Immunobiology"},{"key":"10.1016\/j.trim.2016.04.008_bb0140","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1182\/blood-2001-12-0293","article-title":"In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells","volume":"100","author":"Cooper","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.trim.2016.04.008_bb0145","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1182\/blood-2002-11-3392","article-title":"IL-15 is an essential mediator of peripheral NK-cell homeostasis","volume":"101","author":"Ranson","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.trim.2016.04.008_bb0150","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1182\/blood.V97.1.14","article-title":"Interleukin 15: biology and relevance to human disease","volume":"97","author":"Fehniger","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.trim.2016.04.008_bb0155","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1182\/blood-2005-07-3032","article-title":"Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells","volume":"107","author":"Coenen","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.trim.2016.04.008_bb0160","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/01.tp.0000259752.13304.0b","article-title":"Isolation of large numbers of mesenchymal stem cells from the washings of bone marrow collection bags: characterization of fresh mesenchymal stem cells","volume":"83","author":"Mageed","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2016.04.008_bb0165","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.trim.2016.04.008_bb0170","doi-asserted-by":"crossref","first-page":"6576","DOI":"10.1182\/blood-2009-02-203943","article-title":"MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2","volume":"113","author":"Spaggiari","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.trim.2016.04.008_bb0175","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1182\/blood-2005-07-2775","article-title":"Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation","volume":"107","author":"Spaggiari","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.trim.2016.04.008_bb0180","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1089\/scd.2013.0028","article-title":"IFN-gamma stimulated human umbilical-tissue-derived cells potently suppress NK activation and resist NK-mediated cytotoxicity in vitro","volume":"22","author":"Noone","year":"2013","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.trim.2016.04.008_bb0185","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1634\/stemcells.2008-0687","article-title":"Reciprocal interactions between human mesenchymal stem cells and gammadelta T cells or invariant natural killer T cells","volume":"27","author":"Prigione","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.trim.2016.04.008_bb0190","doi-asserted-by":"crossref","first-page":"143463","DOI":"10.1155\/2014\/143463","article-title":"Interaction with mesenchymal stem cells provokes natural killer cells for enhanced IL-12\/IL-18-induced interferon-gamma secretion","volume":"2014","author":"Thomas","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.trim.2016.04.008_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2014.06.015","article-title":"Sequential Third-Party Mesenchymal Stromal Cells Therapy for Refractory Acute Graft-Versus-Host Disease","author":"Sanchez-Guijo","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.trim.2016.04.008_bb0200","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/MOT.0000000000000029","article-title":"Mesenchymal stromal (stem) cells to improve solid organ transplant outcome: lessons from the initial clinical trials","volume":"18","author":"Pileggi","year":"2013","journal-title":"Curr. Opin. Organ Transplant."},{"key":"10.1016\/j.trim.2016.04.008_bb0205","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3727\/096368910X536545","article-title":"Human bone marrow stromal cells and skin fibroblasts inhibit natural killer cell proliferation and cytotoxic activity","volume":"20","author":"Pradier","year":"2011","journal-title":"Cell Transplant."},{"key":"10.1016\/j.trim.2016.04.008_bb0210","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1634\/stemcells.2004-0359","article-title":"Interactions between human mesenchymal stem cells and natural killer cells","volume":"24","author":"Sotiropoulou","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.trim.2016.04.008_bb0215","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1002\/eji.201141542","article-title":"Mesenchymal stem cells expanded in human platelet lysate display a decreased inhibitory capacity on T- and NK-cell proliferation and function","volume":"41","author":"Abdelrazik","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.trim.2016.04.008_bb0220","doi-asserted-by":"crossref","first-page":"e13294","DOI":"10.1371\/journal.pone.0013294","article-title":"Renal transplant immunosuppression impairs natural killer cell function in vitro and in vivo","volume":"5","author":"Morteau","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.trim.2016.04.008_bb0225","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/leu.2009.269","article-title":"CD3+\/CD19+\u2212depleted grafts in HLA-matched allogeneic peripheral blood stem cell transplantation lead to early NK cell cytolytic responses and reduced inhibitory activity of NKG2A","volume":"24","author":"Eissens","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.trim.2016.04.008_bb0230","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/bmt.2013.237","article-title":"Stromal cells-are they really useful for GVHD?","volume":"49","author":"Kaipe","year":"2014","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.trim.2016.04.008_bb0235","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1634\/stemcells.2005-0008","article-title":"Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells","volume":"24","author":"Krampera","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.trim.2016.04.008_bb0240","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.1038\/srep04645","article-title":"Performance-enhanced mesenchymal stem cells via intracellular delivery of steroids","volume":"4","author":"Ankrum","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.trim.2016.04.008_bb0245","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.2353\/ajpath.2010.091173","article-title":"Towards a genetic definition of cancer-associated inflammation: role of the IDO pathway","volume":"176","author":"Prendergast","year":"2010","journal-title":"Am. J. Pathol."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327416300302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327416300302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T21:34:24Z","timestamp":1692308064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327416300302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":49,"alternative-id":["S0966327416300302"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2016.04.008","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Added effects of dexamethasone and mesenchymal stem cells on early Natural Killer cell activation","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2016.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}